Cloudflare Inc. today said it has acquired VoidZero Inc., the open-source company behind Vite and the widely used JavaScript build tools that surround it, in a move to position its developer platform ...
Functional programming, as the name implies, is about functions. While functions are part of just about every programming paradigm, including JavaScript, a functional programmer has unique ...
One of 70 immigrants participating in a naturalization ceremony in Daley Plaza in Chicago in 2014. (Scott Olson/Getty Images) Note: A data release by the Census Bureau in December 2024 may affect ...
The 2023 wildfire season in Canada was one of superlatives and broken records. At approximately 15 Mha, the area burned was by far the highest since the start of comprehensive national reporting (c.
Visual Studio Code is a code editor that is completely free and open-source. It has been developed by Microsoft and is highly regarded by developers due to its lightweight, fast, and extensible design ...
JavaScript is the most in-demand programming language for developer jobs and one of the most versatile languages for full-stack development. Here's what you need to know about JavaScript. JavaScript ...
The season is over. A champion has been crowned. All that's left is to deliver a final, comprehensive ranking of every quarterback who started a game in 2023, judging them by the entire regular season ...
The Corruption Perceptions Index (CPI) scores 180 countries and territories by their perceived levels of public sector corruption, according to experts and business people. The CPI uses a scale from 0 ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Birgitta Böckeler, Distinguished Engineer at ...
The U.S. labor market ended the year strong, creating more than 200,000 jobs in the last month of the year and nearly 2.7 million jobs in all of 2023, when seasonally adjusted. Consumer spending ...
The FDA’s Center for Drug Evaluation and Research (CDER) approved 55 new drugs in 2023, as the small molecule and biologic pharmacopoeia continues to grow. This cohort is nearly 50% bigger than the ...